JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Search

Cartesian Therapeutics Inc

Closed

8.06 0.12

Overview

Share price change

24h

Current

Min

8.03

Max

8.15

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+392.04% upside

Cartesian Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Nov 2025, 22:13 UTC

Earnings

Westpac Raises Dividend Despite 1% Slip in Annual Profit -- Update

2 Nov 2025, 21:23 UTC

Earnings

Westpac Raises Dividend Despite 1% Slip in Annual Profit

2 Nov 2025, 23:43 UTC

Market Talk

Gold Falls on Reports of China's Finance Ministry Ending Tax Incentive for Gold Sales -- Market Talk

2 Nov 2025, 23:34 UTC

Market Talk

Oil Rises as OPEC+ Signals Output-Increase Pause -- Market Talk

2 Nov 2025, 21:00 UTC

Earnings

Westpac Has Set Tech Overhaul Goals and Will Share Progress, CEO Says>WBC.AU

2 Nov 2025, 21:00 UTC

Earnings

Westpac Is Now Executing on Tech Overhaul, CEO Says>WBC.AU

2 Nov 2025, 21:00 UTC

Earnings

Westpac Has Completed Tech Overhaul's Discovery and Planning Phases, CEO Says >WBC.AU

2 Nov 2025, 20:55 UTC

Earnings

Westpac FY Australia Mortgage Lending Up 5% on Year>WBC.AU

2 Nov 2025, 20:55 UTC

Earnings

Westpac FY Institutional Lending Up 17% on Year>WBC.AU

2 Nov 2025, 20:55 UTC

Earnings

Westpac FY Business Lending Up 15% on Year>WBC.AU

2 Nov 2025, 20:46 UTC

Earnings

Westpac Expects Completion in 2H of FY 2026>WBC.AU

2 Nov 2025, 20:46 UTC

Earnings

Westpac Expects CET1 Capital Ratio to Rise by 20 Basis Points>WBC.AU

2 Nov 2025, 20:45 UTC

Earnings

Westpac: Sale Is at Slight Premium to Expected Gross Loan Value at Completion>WBC.AU

2 Nov 2025, 20:44 UTC

Earnings

Westpac Selling to Consortium Including KKR, Pimco and Pepper Money>WBC.AU

2 Nov 2025, 20:43 UTC

Earnings

Westpac Agrees to Sell A$21.4B Rams Mortgage Portfolio>WBC.AU

2 Nov 2025, 20:42 UTC

Earnings

Westpac FY Impairment Provisions A$4.99B Vs. A$5.10B>WBC.AU

2 Nov 2025, 20:41 UTC

Earnings

Westpac FY Net Profit Ex-Notable Items A$7.0B, Down 2% on Year>WBC.AU

2 Nov 2025, 20:40 UTC

Earnings

Westpac FY Customer Deposits A$723.0B Vs. A$673.6B>WBC.AU

2 Nov 2025, 20:39 UTC

Earnings

Westpac FY Total Loans A$851.85B Vs. A$806.77B>WBC.AU

2 Nov 2025, 20:37 UTC

Earnings

Westpac FY24 Impairment Charges 5 Bps of Loans Vs. 7 Bps in FY25>WBC.AU

2 Nov 2025, 20:37 UTC

Earnings

Westpac FY Operating Expenses A$11.92B Vs. A$10.94B>WBC.AU

2 Nov 2025, 20:37 UTC

Earnings

Westpac FY Non-Interest Income A$3.00B Vs. A$2.835B>WBC.AU

2 Nov 2025, 20:36 UTC

Earnings

Westpac FY Net Interest Income A$19.38B Vs. A$18.75B>WBC.AU

2 Nov 2025, 20:35 UTC

Earnings

Westpac FY CET1 Level 2 Capital Ratio 12.5% Vs. 12.5%>WBC.AU

2 Nov 2025, 20:35 UTC

Earnings

Westpac FY Net Interest Margin 1.94% Vs. 1.95%>WBC.AU

2 Nov 2025, 20:35 UTC

Earnings

Westpac Raises Dividend to A$0.77 Vs. A$0.76 >WBC.AU

2 Nov 2025, 20:34 UTC

Earnings

Westpac FY Rev A$22.38B Vs. A$21.59B >WBC.AU

2 Nov 2025, 20:33 UTC

Earnings

Westpac FY Net A$6.92B Vs. Net A$6.99B >WBC.AU

2 Nov 2025, 14:27 UTC

Earnings

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2 Nov 2025, 14:25 UTC

Earnings

Warren Buffett Is Leaving Berkshire Hathaway in Great Shape for His Successor After Profit Results -- Barrons.com

Peer Comparison

Price change

Cartesian Therapeutics Inc Forecast

Price Target

By TipRanks

392.04% upside

12 Months Forecast

Average 40.2 USD  392.04%

High 42 USD

Low 39 USD

Based on 7 Wall Street analysts offering 12 month price targets forCartesian Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Financials

$

help-icon Live chat